A Young Scientist Uplifts The Needs Of Parkinson’s Patients

"I heard elders talk about 'the shakes,' but I now know that language reflects deep historical inequities that have denied us access to healthcare, knowledge, and research that could help us alleviate burdens and strengthen our health—enough with the shakes!" —Senegal Alfred Mabry, in Cell

Parkinson’s disease is the second most common neurodegenerative disorder in the United States. According to a 2022 study, some 90,000 people a year in the US are diagnosed with Parkinson’s. It’s a progressive disease that worsens over time, producing unintended or uncontrollable movements, such as tremors, stiffness, and difficulty with balance and coordination.

Researchers are working to better understand the causes of the disease, how it connects to other health conditions, and how to slow or prevent its effects. Senegal Alfred Mabry is a third year PhD student in neuroscience at Cornell University, and was recently named a recipient of this year’s Rising Black Scientist Award by Cell Press. His research involves interoception—a sense that allows the body to monitor its own processes—and the autonomic nervous system. He joins Ira to talk about his research into Parkinson’s disease, and the importance of scientific research being connected to communities.

Transcripts for each segment will be available after the show airs on sciencefriday.com.

Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.